MP44-02 BASELINE LEVELS OF SEMINAL REACTIVE OXYGEN SPECIES PREDICT IMPROVEMENTS IN SPERM FUNCTION FOLLOWING ANTI-OXIDANT THERAPY IN MEN WITH INFERTILITY

INTRODUCTION AND OBJECTIVE: Poor sperm function is a major cause of infertility. There is no established drug therapy to improve sperm function and the EAU guidelines advocate that empiric therapies have a limited role in the treatment of male infertility. However, high levels of seminal oxidative stress has been postulated to contribute to sperm damage. Commercial anti-oxidants such as L-carnitine and acetyl-L-carnitine (LAL) are commonly...